7TM is developing therapeutics targeting 7 transmembrane receptors. They are currently focused on metabolic diseases, include obesity, diabetes, and cardiovascular disease.
More
7TM Pharma
top ↑
top ↑
Facts from the Community
From the BioVenturist base
Medical focus:
View entire collection »Investment Round:
| Amount raised | Currency | Date | web reference |
|---|---|---|---|
|
|
We can also tell you 7TM Pharma is a
If you know more about 7TM Pharma, you can add more facts here »